[1] Danish Breast Cancer Cooperative Group. DBCG.dk.
http://www.dbcg.dk/
[2] Cancer. Cancer.dk.
http://www.cancer.dk/
[3] Lynge, E., Bak, M., Euler-Chelpin, M., Kroman, N., Lernevall, A., Mogensen, N.B., Schwartz, W., Wronecki, A.J. and Vejborg, I. (2017) Outcome of Breast Cancer Screening in Denmark. BMC Cancer, 17, 897.
[4] Liberman, L., Gougoutas, C.A., Zakowski, M.F., et al. (2001) Calcifications Highly Suggestive of Malignancy: Comparison of Breast Biopsy Methods. American Journal of Roentgenology, 177, 165-172.
[5] Philpotts, L.E., Shaheen, N.A., Carter, D., Lange, R.C. and Lee, C.H. (1999) Comparison of Rebiopsy Rates after Sterotactic Core Needle Biopsy of the Breast with 11-Gauge Vacuum Suction Probe versus 14-Gauge Needle and Automatic Gun. American Journal of Roentgenology, 172, 683-687.
[6] Maxwell, A.J., Ridley, N.T., Rubin, G., Gilbert, F.J. and Michell, M.S. (2009) The Royal College of Radiologists Breast Group Breast Imaging Classification. Clinical Radiology, 64, 624-627.
https://doi.org/10.1016/j.crad.2009.01.010
[7] Radiologi, Svensk Förening för Medicinsk. Klassifikation av Radiologiska Bilddiagnostiska Fynd i Bröst. Svensk Förening för Medicinsk Radiologi.
http://www.sfmr.se/sidor/sfrb---rekommendationer/
[8] Bell, D., Weerakkody, Y., et al. (2016) Breast Imaging-Reporting and Data System (BI-RADS). Radiopedia.org.
https://radiopaedia.org/articles/breast-imaging-reporting-and-data-system-birads
[9] Liberman, L. (2002) Percutaneous Image-Guided Core Breast Biopsy. Radiologic Clinics of North America, 40, 483-500.
[10] Sharma, E.S. (2014) Estimation for Lesion Depth in Mammograms Using Stereotactic Biopsy. International Journal of Advanced Research in Computer Science and Software Engineering, 4, No. 2.
http://ijarcsse.com/Before_August_2017/docs/papers/Volume_4/2_February2014/V4I2-0181.pdf
[11] Nakamura, Y., Urashima, M., Mutsuura, M., Nishihara, R., Itoh, A., Kagemoto, M. and Hagiki, K. (2010) Stereotactic Directional Vacuum-Assisted Breast Biopsy using Lateral Approach. Breast Cancer, 17, 286-289.
[12] Sim, Y.T., Litherland, J., Lindsay, E., Hendry, P., Brauer, K., Dobson, H., Cordiner, C., Galiardi, T. and Smart, L. (2015) Upgrade of Ductal Carcinoma in Situ on Core Biopsies to Invasive Disease at Final Surgery: A Retrospective Review across the Scottish Breast Screening Programme. Clinical Radiology, 70, 502-506.
[13] Sinn, H.P. and Kreipe, H. (2013) A Brief Overview of the WHO Classification of Breast Tumors. Breast Care, 8, 149-154.
[14] WHO (2012) Classification of Tumors of the Breast. 4th Edition.
[15] Kettritz, U., Morack, G. and Decker, T. (2005) Stereotactic Vacuum-Assisted Breast Biopsies in 500 Women with Microcalcifications: Radiological and Pathological Correlations. European Journal of Radiology, 55, 270-276.
[16] Kettritz, U., Rotter, K., Schreer, I., Murauer, M., Schulz-Wendtland, R., Peter, D. and Heywang-Köhbrunner, S.H. (2004) Stereotactic Vacuum-Assisted Breast Biopsy in 2874 Patients—A Multicenter Study. Cancer, 100, 245-251.
https://doi.org/10.1002/cncr.11887
[17] Uematsu, T., Kasami, M. and Yuen, S. (2008) Usefulness and Limitations of the Japan Mammography Guidelines for the Categorization of Microcalcifications. Breast Cancer, 15, 291-297.
https://doi.org/10.1007/s12282-008-0033-4
[18] Liberman, L., Abrahamson, A.F., Squires, F.B., Morris, E.A. and Dershaw, D.D. (1998) The Breast Imaging Reporting and Data System: Positive Predictive Value of Mammographic Features and Final Assessment Categories. American Journal of Roentgenology, 171, 35-40.
[19] Mendez, A., Cabanillas, F., Echenique, M., et al. (2004) Mammographic Features and Correlation with Biopsy Findings using 11-Gauge Stereotactic Vacuum-Assisted Breast Biopsy (SVABB). Annals of Oncology, 15, 450-454.
[20] Sanders, M.A., Roland, L. and Sahoo, S. (2010) Clinical Implications of Subcategorizing BI-RADS 4 Breast Lesions Associated with Microcalcification: A Radiology-Pathology Correlation Study. The Breast Journal, 16, 28-31.
[21] Steger, H.E. and Pape, C. (1972) Beitrag zur Feinstruktur der sogenannten Mikrokalzifikation in Mamma tumoren. Zentralblatt Fur Allgemeine Pathologie, 115, 106.
[22] EUSOMA (European Society of Breast Cancer Specialists).
https://www.eusoma.org/
[23] Chang, J.H., Vines, E., Bertsch, H., et al. (2001) The Impact of a Multidisciplinary Breast Cancer Center on Recommendations for Patient Management: The University of Pennsylvania Experience. Cancer, 91, 1231-1237.
https://www.ncbi.nlm.nih.gov/pubmed/11283921
[24] Wiley, E.L. and Keh, P. (1999) Diagnostic Discrepancies in Breast Specimens Subjected to Gross Reexamination. The American Journal of Surgical Pathology, 23, 876-879.
https://www.ncbi.nlm.nih.gov/pubmed/10435555
[25] Hansen, R.P., Vested, P., et al. (2011) Time Intervals from First Symptoms to Treatment of Cancer: A Cohort Study of 2212 Newly Diagnosed Cancer Patients. BMC Health Services Research, 11, 284.